VADFX
Price
$76.88
Change
+$0.31 (+0.40%)
Updated
Jul 16 closing price
Net Assets
6.7B
VFINX
Price
$581.45
Change
+$3.10 (+0.54%)
Updated
Jul 17 closing price
Net Assets
1.49T
Interact to see
Advertisement

VADFX vs VFINX

Header iconVADFX vs VFINX Comparison
Open Charts VADFX vs VFINXBanner chart's image
Invesco Equally-Wtd S&P 500 R6
Price$76.88
Change+$0.31 (+0.40%)
VolumeN/A
Net Assets6.7B
Vanguard 500 Index Investor
Price$581.45
Change+$3.10 (+0.54%)
VolumeN/A
Net Assets1.49T
VADFX vs VFINX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VADFX vs. VFINX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VADFX is a StrongBuy and VFINX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.49T vs. VADFX (6.7B). VADFX pays higher dividends than VFINX: VADFX (1.57) vs VFINX (1.12). VADFX was incepted earlier than VFINX: VADFX (13 years) vs VFINX (49 years). VADFX (0.18) is less costly to investors than VFINX (0.14). VADFX is a more actively managed with annual turnover of: 22.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than VADFX: VFINX (0) vs VADFX (1000000). VFINX annual gain was more profitable for investors over the last year : 12.15 vs. VADFX (0.82). VFINX return over 5 years is better than : 94.41 vs. VADFX (36.71).
VADFXVFINXVADFX / VFINX
Total Expense Ratio0.180.14129%
Annual Report Gross Expense Ratio0.180.14129%
Fund Existence13 years49 years-
Gain YTD4.8626.56374%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.7B1.49T0%
Annual Yield % from dividends1.571.12141%
Returns for 1 year0.8212.157%
Returns for 3 years19.3663.6430%
Returns for 5 years36.7194.4139%
Returns for 10 years70.94194.7336%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XTLB1.750.24
+15.89%
XTL Biopharmaceuticals Ltd
CCCC2.180.16
+7.92%
C4 Therapeutics
CNR75.342.83
+3.90%
Core Natural Resources Inc
DCOM28.850.49
+1.73%
Dime Community Bancshares
INVH32.260.05
+0.16%
Invitation Homes